BR0112939A - Compostos para o tratamento de distúrbios de dependência - Google Patents
Compostos para o tratamento de distúrbios de dependênciaInfo
- Publication number
- BR0112939A BR0112939A BR0112939-2A BR0112939A BR0112939A BR 0112939 A BR0112939 A BR 0112939A BR 0112939 A BR0112939 A BR 0112939A BR 0112939 A BR0112939 A BR 0112939A
- Authority
- BR
- Brazil
- Prior art keywords
- disorders
- treatment
- compounds
- dependence
- addiction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
"COMPOSTOS PARA O TRATAMENTO DE DISTúRBIOS DE DEPENDêNCIA". O tratamento de distúrbios de dependência, distúrbios de uso de substancias psicoativas, distúrbios de intoxicação, distúrbios de inalação, dependência alcoólica, dependência ao tabaco e dependência à nicotina que usa uma amina heterocíclica, um fenilazacicloalcano, uma cabergolina ou um agente ativo de amina bicíclica aromática, ou um derivado ou sal farmaceuticamente aceitável de quaisquer dos referidos agentes ativos é descrito nessa.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22571400P | 2000-08-16 | 2000-08-16 | |
US26361001P | 2001-01-23 | 2001-01-23 | |
PCT/US2001/025603 WO2002013807A2 (en) | 2000-08-16 | 2001-08-13 | Compounds for the treatment of addictive disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0112939A true BR0112939A (pt) | 2005-11-01 |
Family
ID=26919847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0112939-2A BR0112939A (pt) | 2000-08-16 | 2001-08-13 | Compostos para o tratamento de distúrbios de dependência |
Country Status (17)
Country | Link |
---|---|
US (2) | US6841557B2 (pt) |
EP (1) | EP1363634A2 (pt) |
JP (1) | JP2004506621A (pt) |
KR (1) | KR20030024877A (pt) |
AR (1) | AR030364A1 (pt) |
AU (2) | AU2001283393B2 (pt) |
BR (1) | BR0112939A (pt) |
CA (1) | CA2413762A1 (pt) |
CZ (1) | CZ200380A3 (pt) |
EA (1) | EA200300271A1 (pt) |
IL (1) | IL154378A0 (pt) |
MX (1) | MXPA03001472A (pt) |
NO (1) | NO20030717D0 (pt) |
NZ (1) | NZ524741A (pt) |
PE (1) | PE20020288A1 (pt) |
PL (1) | PL363365A1 (pt) |
WO (1) | WO2002013807A2 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
SE521512C2 (sv) * | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
MXPA05003513A (es) * | 2002-10-04 | 2005-06-03 | Pharmacia Corp | Composiciones farmaceuticas para tratamiento de enfermedad de parkinson. |
WO2004056363A2 (en) | 2002-12-20 | 2004-07-08 | Niconovum Ab | A physically and chemically stable nicotine-containing particulate material |
US20070134169A1 (en) * | 2005-12-11 | 2007-06-14 | Rabinoff Michael D | Methods for smoking cessation or alcohol cessation or other addiction cessation |
CA2646942C (en) | 2006-03-16 | 2014-07-29 | Niconovum Ab | Improved snuff composition |
DK2618826T3 (en) * | 2010-09-20 | 2016-08-01 | A Carlsson Res Ab | Phenylpiperdine FOR TREATMENT OF DEMENTIA |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4526892A (en) | 1981-03-03 | 1985-07-02 | Farmitalia Carlo Erba, S.P.A. | Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas |
US4935429A (en) * | 1985-10-25 | 1990-06-19 | Dackis Charles A | Method of treating psychostimulant addiction |
US4800204A (en) * | 1987-05-07 | 1989-01-24 | Mueller Peter S | Method of controlling tobacco use |
US4999382A (en) * | 1988-10-26 | 1991-03-12 | Massachusetts Institute Of Technology | Compositions for treating tobacco withdrawal symptoms and methods for their use |
US5273975A (en) | 1989-06-09 | 1993-12-28 | The Upjohn Company | Heterocyclic amines having central nervous system activity |
HU210264B (en) * | 1989-06-09 | 1995-03-28 | Upjohn Co | Process for producing amines of condensed ring-systems containing nitrogen and pharmaceutical compositions containing them |
US5051426A (en) * | 1990-03-27 | 1991-09-24 | Parnell Pharmaceuticals, Inc. | Method for effecting withdrawal from drug dependency |
WO1992000282A1 (en) * | 1990-06-29 | 1992-01-09 | The Upjohn Company | Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity |
JP3176063B2 (ja) | 1991-04-17 | 2001-06-11 | ファルマシア・アンド・アップジョン・カンパニー | 新規中枢神経作用性置換フェニルアザシクロアルカン類 |
TW252979B (pt) * | 1992-12-24 | 1995-08-01 | Erba Carlo Spa | |
CN1046723C (zh) * | 1993-04-06 | 1999-11-24 | 艾博特公司 | 四环化合物、含有它们的药物组合物及其用途 |
ATE182590T1 (de) | 1993-12-28 | 1999-08-15 | Upjohn Co | Heterozyklische verbindungen für die behandlung von kardiovaskular- und zentralnervensystem störungen |
GB9407637D0 (en) * | 1994-04-18 | 1994-06-08 | Erba Carlo Spa | Serotoninergic abeo-ergoline derivatives |
US5874477A (en) * | 1994-08-12 | 1999-02-23 | The University Of Hawaii | Method of treatment for malaria utilizing serotonin receptor ligands |
IL122649A (en) * | 1995-08-11 | 2001-08-26 | Pfizer | (1s, 2s) - 1- (4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol methanesulfonate trihydrate, its use in the preparation of medicaments and pharmaceutical compositions comprising same |
GB9517062D0 (en) * | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
GB9603226D0 (en) * | 1996-02-15 | 1996-04-17 | Pharmacia Spa | Heterocyclyl-ergoline derivatives |
US6001848A (en) * | 1996-03-25 | 1999-12-14 | The Regents Of The University Of California | Bromocriptine for the treatment of alcoholics diagnosed with the D2 dopamine receptor DRD2 A1 allele |
HN1998000118A (es) * | 1997-08-27 | 1999-02-09 | Pfizer Prod Inc | 2 - aminopiridinas que contienen sustituyentes de anillos condensados. |
GB9723544D0 (en) * | 1997-11-07 | 1998-01-07 | Merck Sharp & Dohme | Therapeutic agents |
US20020010197A1 (en) * | 1998-01-13 | 2002-01-24 | John Dixon | Pharmaceutical compositions comprising a compound having dopamine (d2) receptor agonist activity and a compound (b) having beta2-adrenoreceptor agonist activity |
US6448293B1 (en) * | 2000-03-31 | 2002-09-10 | Pfizer Inc. | Diphenyl ether compounds useful in therapy |
CA2405565A1 (en) * | 2000-04-21 | 2001-11-01 | Pharmacia & Upjohn Company | Compounds for treating fibromyalgia and chronic fatigue syndrome |
-
2001
- 2001-08-13 NZ NZ524741A patent/NZ524741A/en unknown
- 2001-08-13 EP EP01962196A patent/EP1363634A2/en not_active Withdrawn
- 2001-08-13 BR BR0112939-2A patent/BR0112939A/pt not_active IP Right Cessation
- 2001-08-13 EA EA200300271A patent/EA200300271A1/ru unknown
- 2001-08-13 AU AU2001283393A patent/AU2001283393B2/en not_active Ceased
- 2001-08-13 PL PL01363365A patent/PL363365A1/xx not_active Application Discontinuation
- 2001-08-13 MX MXPA03001472A patent/MXPA03001472A/es not_active Application Discontinuation
- 2001-08-13 IL IL15437801A patent/IL154378A0/xx unknown
- 2001-08-13 KR KR10-2003-7002252A patent/KR20030024877A/ko not_active Application Discontinuation
- 2001-08-13 CA CA002413762A patent/CA2413762A1/en not_active Abandoned
- 2001-08-13 WO PCT/US2001/025603 patent/WO2002013807A2/en not_active Application Discontinuation
- 2001-08-13 JP JP2002518953A patent/JP2004506621A/ja active Pending
- 2001-08-13 CZ CZ200380A patent/CZ200380A3/cs unknown
- 2001-08-13 AU AU8339301A patent/AU8339301A/xx active Pending
- 2001-08-14 US US09/929,666 patent/US6841557B2/en not_active Expired - Fee Related
- 2001-08-16 PE PE2001000816A patent/PE20020288A1/es not_active Application Discontinuation
- 2001-08-16 AR ARP010103925A patent/AR030364A1/es unknown
-
2002
- 2002-11-15 US US10/295,331 patent/US20030078273A1/en not_active Abandoned
-
2003
- 2003-02-14 NO NO20030717A patent/NO20030717D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL363365A1 (en) | 2004-11-15 |
JP2004506621A (ja) | 2004-03-04 |
EP1363634A2 (en) | 2003-11-26 |
NZ524741A (en) | 2005-01-28 |
KR20030024877A (ko) | 2003-03-26 |
WO2002013807A2 (en) | 2002-02-21 |
AU2001283393B2 (en) | 2005-09-22 |
NO20030717L (no) | 2003-02-14 |
US20020049206A1 (en) | 2002-04-25 |
IL154378A0 (en) | 2003-09-17 |
EA200300271A1 (ru) | 2004-02-26 |
AR030364A1 (es) | 2003-08-20 |
MXPA03001472A (es) | 2003-06-06 |
CA2413762A1 (en) | 2002-02-21 |
PE20020288A1 (es) | 2002-03-31 |
US20030078273A1 (en) | 2003-04-24 |
WO2002013807A3 (en) | 2003-09-25 |
AU8339301A (en) | 2002-02-25 |
NO20030717D0 (no) | 2003-02-14 |
US6841557B2 (en) | 2005-01-11 |
CZ200380A3 (cs) | 2004-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0107983A (pt) | Uso de pramipexol para o tratamento de enfermidades decorrentes de vìcios | |
BR0205722A (pt) | Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor | |
CO5271759A1 (es) | Formulacion en solucion que contiene una mezcla de disolventes | |
BR0307050A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, sal farmaceuticamente aceitável, e, uso de um composto ou sal | |
BR9812046A (pt) | Compostos, processos para a preperação do composto e para tratar um paciente humano ou animal, composição farmacêutica, e, uso de um composto | |
TW329387B (en) | Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate | |
BR0015908A (pt) | Emprego de compostos org nicos no tratamento de doenças | |
BRPI0515567A (pt) | combinações terapêuticas compreendendo inibidor de poli (adp-ribose) polimerase | |
ES2164040T1 (es) | Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos. | |
BR0314488A (pt) | Composto, composição farmacêutica e métodos de tratamento | |
BR0314271A (pt) | Forma de dosagem oral sólida útil para administração oral transmucosal, e, métodos de reduzir apetências por nicotina, e, uso de tabaco | |
BR0210075A (pt) | Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou distúrbios da debilitação intelectual e de fadiga de vÈo, cessamento de fumar, dependência de nicotina, dores, e para a colite ulcerativa | |
PT1117403E (pt) | Antagonistas de mglurs para o tratamento da dor e ansiedade | |
BR9809508A (pt) | Agente terapêutico para disfunção de ereção | |
SE9704644D0 (sv) | New use | |
BR0112939A (pt) | Compostos para o tratamento de distúrbios de dependência | |
PT1202727E (pt) | Utilizacao de agonistas de receptores gabab e seus derivados farmaceuticamente aceitaveis, na terapia para manter a abstinencia de nicotina em pacientes dependentes de nicotina | |
PT1069900E (pt) | Novos tratamentos para disturbios nervosos | |
BR9913982A (pt) | Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares | |
BRPI0415651A (pt) | métodos para tratar, prevenir, modificar e/ou administrar fibromialgia, e para reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo em um paciente sofrendo de fibromialgia, e, composição farmacêutica | |
BR9812982A (pt) | Agente anti-reumático | |
BR0109119A (pt) | Uso de (r)-(-)-2-[5-(4-fluorofenil)-3-piridilmetil-aminometil]-cr omano e seus sais fisiologicamente aceitáveis | |
BR0017367A (pt) | Uso de melagatran ou de um seu derivado farmaceuticamente aceitável, método de tratamento de um distúrbio isquêmico em um paciente tendo, ou sob risco de ter, fibrilação atrial não-valvular, e, formulação farmacêutica | |
BR0009327A (pt) | Composição farmacêutica para a terapia de sintomas do trato urinário inferior | |
BR0211323A (pt) | Combinação de ingredientes ativos, uso de uma combinação de ingredientes ativos e método de terapia farmacológica de dependência de nicotina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6O, 7O E 8O ANUIDADES. |
|
B08J | Incorrect entry in the gazette republished [chapter 8.10 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2021 DE 29/09/2009. TEXTO CORRETO: REFERENTE A 7A, 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AOS DESPACHOS PUBLICADOS NA RPI 2021 DE 29/09/2009 E RPI 2090 DE 25/01/2011. |